NCT04940507: BRAINFUL (BRAIN) Tumor Focused Ultrasound-enabled Liquid Biopsy Trial

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with a region of treatment located less than 1.0 cm from the inner table of the skull, on skull base, or in the posterior fossa

Comments are closed.

Up ↑